Evidence map›Paper›PMID 20304920›Full record

ArticleThe Journal of biological chemistry2010

Convertase inhibitory properties of Staphylococcal extracellular complement-binding protein.

Ilse Jongerius, Brandon L Garcia, Brian V Geisbrecht, Jos A G van Strijp, Suzan H M Rooijakkers

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Pathogens (Basel, Switzerland) · 2025
    Review
  3. Article
  4. Review
  5. CipA mediates complement resistance ofFrontiers in immunology · 2022
    Article
  6. Article
  7. Review
  8. Complement Inactivation Strategy ofInternational journal of molecular sciences · 2021
    Article
  9. Review
  10. Immune Evasion byMicrobiology spectrum · 2019
    Review
  11. Article
  12. Review
  13. Article
  14. Novel Evasion Mechanisms of the Classical Complement Pathway.Journal of immunology (Baltimore, Md. : 1950) · 2016
    Review
  15. Article
  16. Review
  17. Article
  18. Staphylococcal manipulation of host immune responses.Nature reviews. Microbiology · 2015
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Ilse JongeriusDepartment of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands. Electronic address: i.jongerius@umcutrecht.nl.
Brandon L GarciaSchool of Biological Science, University of Missouri, Kansas City, Missouri 64110.
Brian V GeisbrechtSchool of Biological Science, University of Missouri, Kansas City, Missouri 64110.
Jos A G van StrijpDepartment of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Suzan H M RooijakkersDepartment of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
University Medical Center Utrecht · NLUniversity of Missouri–Kansas City · US

Funding

Structure Function Analysis of Staphylococcal Complement InhibitorsR01AI071028 · NIAID · UNIVERSITY OF MISSOURI KANSAS CITY · PI GEISBRECHT, BRIAN V · 2008 to 2012
$1.5M
NIAID NIH HHS AI071028NIAID NIH HHS R01 AI071028
6 · The paper itself

Abstract

The human pathogen Staphylococcus aureus secretes several complement evasion molecules to combat the human immune response. Extracellular complement-binding protein (Ecb) binds to the C3d domain of C3 and thereby blocks C3 convertases of the alternative pathway and C5 convertases via all complement pathways. Inhibition of C5 convertases results in complete inhibition of C5a generation and subsequent neutrophil migration. Here, we show that binding of Ecb to the C3d domain of C3b is crucial for inhibition of C5 convertases. Ecb does not interfere with substrate binding to convertases but prevents formation of an active convertase enzyme.

Indexed as

Complement C3-C5 ConvertasesEnzyme-Linked Immunosorbent AssayProtein BindingStaphylococcus aureusComplement C3-C5 Convertases

Identifiers

PMID20304920
PMCPMC2865291
OpenAlexW2076389024

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.